Anna Hunt is an associate in the firm’s health care group, advising clients on compliance, clinical research, fraud and abuse, drug pricing, and other regulatory matters. She also assists with corporate transactions and government investigations involving the health care industry. Since joining the firm in 2024, Anna has co-authored articles on health care regulatory topics including the 340B Drug Pricing Program, Medicare reimbursement, FDA guidance on clinical trials, and OIG special fraud alerts. Anna maintains an active pro bono practice, providing legal assistance to veterans, immigrants, and individuals facing housing challenges.
Anna earned her J.D. from Boston College Law School, where she was class valedictorian. During law school, she served as Editor in Chief of the Law Review, was a teaching assistant for legal research, writing, and criminal practice courses, and interned for the Honorable Bruce M. Selya on the U.S. Court of Appeals for the First Circuit. Before law school, Anna worked as a case manager supporting individuals with mental illness and housing instability.